Evidence map›Paper›PMID 19824915›Full record

ArticleImmunology2010

Increased number and function of natural killer cells in human immunodeficiency virus 1-positive subjects co-infected with herpes simplex virus 2.

Brian R Long, Ann E Erickson, Joan M Chapman, Jason D Barbour, Bien-Aimee N Vu, Emily L Ho, Lewis L Lanier, Mariana M Sauer, Karina I Carvalho, Douglas F Nixon and 1 more

Open access · greenAbstract read
In one paragraph

Article in Immunology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Modulation of natural killer cell activity by viruses.Current opinion in microbiology · 2010
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Brian R LongDivision of Experimental Medicine, Department of Medicine, University of California, San Francisco, CA 94110, USA.
Ann E Erickson
Joan M Chapman
Jason D Barbour
Bien-Aimee N Vu
Emily L Ho
Lewis L Lanier
Mariana M Sauer
Karina I Carvalho
Douglas F Nixon
Esper G Kallas
University of California, San Francisco · USUniversidade Federal de São Paulo · BR

Funding

University of California, Berkeley (UCB)/University of *D43TW000003 · FIC · UNIVERSITY OF CALIFORNIA BERKELEY · PI REINGOLD, ARTHUR L · 1988 to 2013
$16.7M
NK Cells and HIV InfectionP01AI064520 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI NIXON, DOUGLAS F · 2005 to 2009
$6.2M
Innate NKT Cells in HIV InfectionR37AI052731 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI NIXON, DOUGLAS F · 2007 to 2016
$3.1M
Innate NKT Cells in HIV InfectionR01AI052731 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI NIXON, DOUGLAS F · 2002 to 2006
$2.1M
Cell Mediated Immunity in HIV Infected ChildrenR01AI060379 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI NIXON, DOUGLAS F · 2005 to 2009
$1.6M
Variation in Immune Activation in HIV-1 Infected PersonsK01AI066917 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BARBOUR, JASON DAVID · 2005 to 2009
$608k
Bioinformatic Mapping of HIV-1 Nef Manipulation of T-Cell Activation and FunctionR21AI076014 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BARBOUR, JASON DAVID · 2007 to 2008
$421k
Cell Mediated Immunity in HIV Infected ChildrenR21AI060379 · NIAID · J. DAVID GLADSTONE INSTITUTES · PI NIXON, DOUGLAS F · 2004 to 2004
$374k
FIC NIH HHS D43 TW000003FIC NIH HHS D43 TW00003NIAID NIH HHS AI052731NIAID NIH HHS AI060379NIAID NIH HHS AI064520NIAID NIH HHS AI-066917NIAID NIH HHS AI-076014NIAID NIH HHS K01 AI066917NIAID NIH HHS P01 AI064520NIAID NIH HHS R01 AI052731NIAID NIH HHS R01 AI060379NIAID NIH HHS R21 AI060379NIAID NIH HHS R21 AI076014NIAID NIH HHS R37 AI052731
6 · The paper itself

Abstract

Natural killer (NK) cells bridge the interface between innate and adaptive immunity and are implicated in the control of herpes simplex virus 2 (HSV-2) infection. In subjects infected with human immunodeficiency virus 1 (HIV-1), the critical impact of the innate immune response on disease progression has recently come into focus. Higher numbers of NK cells are associated with lower HIV-1 plasma viraemia. Individuals with the compound genotype of killer cell immunoglobulin-like receptor (KIR) 3DS1 and human leucocyte antigen (HLA)-Bw4-80I, or who have alleles of KIR3DL1 that encode proteins highly expressed on the NK cell surface, have a significant delay in disease progression. We studied the effect of HSV-2 co-infection in HIV-1-infected subjects, and show that HSV-2 co-infection results in a pan-lymphocytosis, with elevated absolute numbers of CD4(+) and CD8(+) T cells, and NK cells. The NK cells in HSV-2 co-infected subjects functioned more efficiently, with an increase in degranulation after in vitro stimulation. The number of NK cells expressing the activating receptors NKp30 and NKp46, and expressing KIR3DL1 or KIR3DS1, was inversely correlated with HIV-1 plasma viral load in subjects mono-infected with HIV-1, but not in subjects co-infected with HSV-2. This suggests that HSV-2 infection mediates changes within the NK cell population that may affect immunity in HIV-1 infection.

Indexed as

AdultCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCell CountCells, CulturedCytotoxicity, ImmunologicDisease ProgressionFemaleHerpes SimplexHerpesvirus 2, HumanHistocompatibility TestingHIV-1HIV SeropositivityHLA-B AntigensHumansImmunity, InnateHLA-B AntigensHLA-Bw4 antigenKIR3DL1 protein, humanReceptors, KIR3DL1Receptors, KIR3DS1

Identifiers

PMID19824915
PMCPMC2814461
OpenAlexW2040111706

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.